154 related articles for article (PubMed ID: 21141971)
1. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.
Sung HJ; Ahn JM; Yoon YH; Rhim TY; Park CS; Park JY; Lee SY; Kim JW; Cho JY
J Proteome Res; 2011 Mar; 10(3):1383-95. PubMed ID: 21141971
[TBL] [Abstract][Full Text] [Related]
2. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
5. The Haptoglobin β chain as a supportive biomarker for human lung cancers.
Kang SM; Sung HJ; Ahn JM; Park JY; Lee SY; Park CS; Cho JY
Mol Biosyst; 2011 Apr; 7(4):1167-75. PubMed ID: 21253648
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
7. Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera.
Sung HJ; Jeon SA; Ahn JM; Seul KJ; Kim JY; Lee JY; Yoo JS; Lee SY; Kim H; Cho JY
J Proteomics; 2012 Apr; 75(7):2170-80. PubMed ID: 22300576
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Khan N; Cromer CJ; Campa M; Patz EF
Cancer; 2004 Jul; 101(2):379-84. PubMed ID: 15241837
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum amyloid A as a biomarker for gastric cancer.
Chan DC; Chen CJ; Chu HC; Chang WK; Yu JC; Chen YJ; Wen LL; Huang SC; Ku CH; Liu YC; Chen JH
Ann Surg Oncol; 2007 Jan; 14(1):84-93. PubMed ID: 17063306
[TBL] [Abstract][Full Text] [Related]
10. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].
Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549
[TBL] [Abstract][Full Text] [Related]
11. [Application of liquid chip-mass spectrometry technology for screening serum biomarker proteins in lung squamous cell carcinoma].
Bu LN; Yang SY; Du J; Nan YD; Lin XL; Zheng HD; Huo SF; Shang WL; Liu YF
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1662-6. PubMed ID: 19957521
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells.
Thorn CF; Lu ZY; Whitehead AS
Eur J Immunol; 2003 Sep; 33(9):2630-9. PubMed ID: 12938239
[TBL] [Abstract][Full Text] [Related]
13. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients.
Li M; Xiao T; Zhang Y; Feng L; Lin D; Liu Y; Mao Y; Guo S; Han N; Di X; Zhang K; Cheng S; Gao Y
Lung Cancer; 2010 Sep; 69(3):341-7. PubMed ID: 20060194
[TBL] [Abstract][Full Text] [Related]
16. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
Connolly M; Marrelli A; Blades M; McCormick J; Maderna P; Godson C; Mullan R; FitzGerald O; Bresnihan B; Pitzalis C; Veale DJ; Fearon U
J Immunol; 2010 Jun; 184(11):6427-37. PubMed ID: 20435930
[TBL] [Abstract][Full Text] [Related]
17. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
[TBL] [Abstract][Full Text] [Related]
18. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
Gutfeld O; Prus D; Ackerman Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
J Histochem Cytochem; 2006 Jan; 54(1):63-73. PubMed ID: 16116035
[TBL] [Abstract][Full Text] [Related]
19. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
20. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer.
Cai XW; Shedden K; Ao X; Davis M; Fu XL; Lawrence TS; Lubman DM; Kong FM
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):867-76. PubMed ID: 20510197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
